Home » Topics » BioWorld Science

BioWorld Science
RSS

Xencor opens enrollment in phase I study of XmAb-20717 for advanced solid tumors

June 1, 2018

FDA clears Janssen to begin phase Ib/II trial of JNJ-68284528 in multiple myeloma

May 31, 2018

Researchers describe potent antitumoral activity of KY-1055, a dual anti-ICOS/PD-L1 antibody

May 31, 2018

Syndax and Nektar collaborate to study combination of NKTR-214 with entinostat in melanoma

May 31, 2018

Encouraging results seen with pegilodecakin plus pembrolizumab or nivolumab in NSCLC, RCC patients

May 31, 2018

Five Prime collaborates with Roche on IHC companion diagnostic assays

May 31, 2018

FDA places clinical hold on IND for CTX-001 in sickle cell disease

May 31, 2018

Phase II EQUATOR study of filgotinib in psoriatic arthritis meets primary endpoint

May 31, 2018

Natural killer cell phenotype GAIA-102 has antitumor activity

May 31, 2018

Treeway completes phase I study of oral formulation of TW-001 for ALS

May 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...